Inventor · disambiguated record
Changjin Fu
Also filed as: FU CHANGJIN
7 granted patents·5 pending applications·3 citations·filing 2013–2023
72Inventor score
Files withJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD8ATOM BIOSCIENCE AMERICA CORP2ATOM THERAPEUTICS CO LTD2
Top patents by PatentIndex Score
12 records- 0175US11643405B2Compound for treatment or prevention of liver diseasesJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2019·Granted May 9, 2023·1 cites·8 claims
- 0272US10875865B2URAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 29, 2020·1 cites·3 claims
- 0372US10399971B2Compound for treating or preventing hyperuricemia or goutJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 3, 2019·1 cites·9 claims
- 0458US2025282753A1Compounds useful for reducing uric acidATOM BIOSCIENCE AMERICA CORP·Filed 2023·Application pending·0 cites
- 0558US2025289809A1Compounds useful for goutATOM BIOSCIENCE AMERICA CORP·Filed 2023·Application pending·0 cites
- 0654US2025129012A1Anti-inflammatory and analgesic compounds and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0754US2024262808A1Xanthine oxidase inhibitorJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0853USRE50083EURAT1 inhibitor and use thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 20, 2024·0 cites·20 claims
- 0953US2025368639A1Solid forms of a compound for treating or preventing hyperuricemia or goutATOM THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 1041US12331047B2Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrileATOM THERAPEUTICS CO LTD·Filed 2020·Granted Jun 17, 2025·0 cites·6 claims
- 1141US9802907B22-aryl selenazole compound and pharmaceutical composition thereofJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2013·Granted Oct 31, 2017·0 cites·21 claims
- 1233US10005744B2Compounds for the treatment or prevention of breast cancerJIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 26, 2018·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Changjin Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →